Bristol-Myers Squibb Company Celegne Contingent ValueBristol-Myers Squibb Company Celegne Contingent ValueBristol-Myers Squibb Company Celegne Contingent Value

Bristol-Myers Squibb Company Celegne Contingent Value

No trades
See on Supercharts
Previous close
Open
Volume
Dividend yield (indicated)

About Bristol-Myers Squibb Company Celegne Contingent Value

CEO
Christopher S. Boerner
Headquarters
Princeton
Website
Employees (FY)
‪34.1 K‬
Founded
1933
FIGI
BBG001732JG2
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.